The neurogenic bladder in Multiple Sclerosis multiple sclerosis:: review of the literature and proposal of management guidelines

被引:290
作者
de Seze, Marianne [1 ]
Ruffion, Alain
Denys, Pierre
Joseph, Pierre-Aloin
Perrouin-Verbe, Brigitte
机构
[1] Univ Bordeaux 2, CHU Pellegrin, Serv Med Phys & Readaptat, Unite Evaluat & Traitement Handicap Urinaire,Equi, F-33076 Bordeaux, France
[2] Hop Henry Gabrielle, CHU Lyon, Serv Urol, F-69565 St Genis Laval, France
[3] Hop Raymond Poincare, AP HP, Serv Reeducat Neurol, F-92380 Garches, France
[4] CHU Nantes, Hop St Jacques, Serv Med Phys & Readaptat, F-44093 Nantes, France
关键词
multiple sclerosis; neurogenic bladder; overactive bladder; upper urinary tract; abnormalities; ureterohydronephrosis; urinary tract infection;
D O I
10.1177/1352458506075651
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Vesicourethral dysfunction is very frequent in multiple sclerosis (MS) and has functional consequences for patients' quality of life and also an organic impact following complications of the neurogenic bladder on the upper urinary tract. While the functional impact and its management are well documented in the literature, the organic impact remains underestimated and there are no consensual practical guidelines for the screening and prevention of MS neurogenic bladder complications. The aim of this review of the literature, focused on identifying the risk factors of urinary tract complications in MS, is to put forward well informed considerations to help in the definition of practical guidelines for the follow-up of the neurogenic bladder in MS in order to improve its prevention and patient management. Four main risk factors have been identified for upper urinary tract damage: the duration of MS, the presence of an indwelling catheter, high-amplitude neurogenic detrusor contractions and permanent high detrusor pressure. Detrusor-sphincter dyssynergia, age over 50 and male sex may form three additional risk factors. Recommendations for long-term urological follow-up, taking into account these specific risks are constructed according to the procedures recommended by the French Health Authorities. Multiple Sclerosis 2007; 13: 915-928. http://msj.sagepub.com.
引用
收藏
页码:915 / 928
页数:14
相关论文
共 65 条
[1]  
Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
[2]  
Amarenco G, 1995, REV NEUROL, V151, P722
[3]  
Amarenco G, 1996, PRESSE MED, V25, P1007
[4]  
*ANAES, 2000, GUID LIT AN SCOR REC
[5]   ABNORMALITIES OF DETRUSOR AND SPHINCTER FUNCTION IN MULTIPLE-SCLEROSIS [J].
ANDERSEN, JT ;
BRADLEY, WE .
BRITISH JOURNAL OF UROLOGY, 1976, 48 (03) :193-198
[6]  
ANDERSON KE, 2005, INCONTINENCE MANAGEM, V2, P808
[7]   Bladder dysfunction and management in multiple sclerosis [J].
Andrews, KL ;
Husmann, DA .
MAYO CLINIC PROCEEDINGS, 1997, 72 (12) :1176-1183
[8]  
[Anonymous], 1992, J AM PARAPLEGIA SOC, V15, P194
[9]   Relationship of bladder dysfunction to lesion site in multiple sclerosis [J].
Araki, I ;
Matsui, M ;
Ozawa, K ;
Takeda, M ;
Kuno, S .
JOURNAL OF UROLOGY, 2003, 169 (04) :1384-1387
[10]   RELATIONSHIP BETWEEN NEUROLOGICAL AND UROLOGICAL STATUS IN PATIENTS WITH MULTIPLE-SCLEROSIS [J].
AWAD, SA ;
GAJEWSKI, JB ;
SOGBEIN, SK ;
MURRAY, TJ ;
FIELD, CA .
JOURNAL OF UROLOGY, 1984, 132 (03) :499-502